Related Articles by Review for PMID: 18483303

Year	Number of Results
2008	3
2011	2
2012	2
2013	1
2014	1
2018	1
2022	1
2024	0

1

Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.

Wang X, Chen W, Zeng W, Bai L, Tesfaigzi Y, Belinsky SA, Lin Y. Wang X, et al. Mol Cancer Ther. 2008 May;7(5):1156-63. doi: 10.1158/1535-7163.MCT-07-2183. Mol Cancer Ther. 2008. PMID: 18483303 Free PMC article.

2

Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.

Hassanzadeh A, Farshdousti Hagh M, Alivand MR, Akbari AAM, Shams Asenjan K, Saraei R, Solali S. Hassanzadeh A, et al. J Cell Physiol. 2018 Oct;233(10):6470-6485. doi: 10.1002/jcp.26585. Epub 2018 May 9. J Cell Physiol. 2018. PMID: 29741767 Review.

3

c-FLIP, a master anti-apoptotic regulator.

Safa AR. Safa AR. Exp Oncol. 2012 Oct;34(3):176-84. Exp Oncol. 2012. PMID: 23070002 Free PMC article. Review.

4

Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

Safa AR, Day TW, Wu CH. Safa AR, et al. Curr Cancer Drug Targets. 2008 Feb;8(1):37-46. doi: 10.2174/156800908783497087. Curr Cancer Drug Targets. 2008. PMID: 18288942 Free PMC article. Review.

5

FLIP as an anti-cancer therapeutic target.

Yang JK. Yang JK. Yonsei Med J. 2008 Feb 29;49(1):19-27. doi: 10.3349/ymj.2008.49.1.19. Yonsei Med J. 2008. PMID: 18306465 Free PMC article. Review.

6

Beyond BCL-2 Inhibition in Acute Myloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway.

Maiti A, Carter BZ, Andreeff M, Konopleva MY. Maiti A, et al. Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):652-658. doi: 10.1016/j.clml.2022.04.001. Epub 2022 Apr 6. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35490155 Review.

7

Targeting Mcl-1 for the therapy of cancer.

Quinn BA, Dash R, Azab B, Sarkar S, Das SK, Kumar S, Oyesanya RA, Dasgupta S, Dent P, Grant S, Rahmani M, Curiel DT, Dmitriev I, Hedvat M, Wei J, Wu B, Stebbins JL, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Quinn BA, et al. Expert Opin Investig Drugs. 2011 Oct;20(10):1397-411. doi: 10.1517/13543784.2011.609167. Epub 2011 Aug 19. Expert Opin Investig Drugs. 2011. PMID: 21851287 Free PMC article. Review.

8

Apoptosis and autophagy in the regulation of T lymphocyte function.

Dunkle A, He YW. Dunkle A, et al. Immunol Res. 2011 Apr;49(1-3):70-86. doi: 10.1007/s12026-010-8195-5. Immunol Res. 2011. PMID: 21128005 Free PMC article. Review.

9

Delving deeper: MCL-1's contributions to normal and cancer biology.

Perciavalle RM, Opferman JT. Perciavalle RM, et al. Trends Cell Biol. 2013 Jan;23(1):22-9. doi: 10.1016/j.tcb.2012.08.011. Epub 2012 Sep 28. Trends Cell Biol. 2013. PMID: 23026029 Free PMC article. Review.

10

Apoptosis and molecular targeting therapy in cancer.

Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N. Hassan M, et al. Biomed Res Int. 2014;2014:150845. doi: 10.1155/2014/150845. Epub 2014 Jun 12. Biomed Res Int. 2014. PMID: 25013758 Free PMC article. Retracted. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year